|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
alkannin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL1B protein] |
CTD |
PMID:30924981 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
alkannin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 protein] |
CTD |
PMID:30924981 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
ISO |
alkannin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased activity of MPO protein] |
CTD |
PMID:30924981 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
ISO |
alkannin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:30924981 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
alkannin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of RELA protein] |
CTD |
PMID:30924981 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rho |
rhodopsin |
multiple interactions |
ISO |
alkannin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of RHO mRNA]; alkannin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of RHO protein] |
CTD |
PMID:30924981 |
|
NCBI chr 4:148,975,597...148,988,693
Ensembl chr 4:148,980,611...148,985,773
|
|
G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
multiple interactions |
ISO |
alkannin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of ROCK1 mRNA]; alkannin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of ROCK1 protein] |
CTD |
PMID:30924981 |
|
NCBI chr18:1,114,532...1,236,345
Ensembl chr18:1,115,905...1,235,571
|
|
G |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
multiple interactions |
ISO |
alkannin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of ROCK2 mRNA]; alkannin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of ROCK2 protein] |
CTD |
PMID:30924981 |
|
NCBI chr 6:39,679,116...39,774,033
Ensembl chr 6:39,679,082...39,774,031
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
alkannin inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF protein] |
CTD |
PMID:30924981 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases activity |
ISO |
Atovaquone results in increased activity of CYP1A2 protein |
CTD |
PMID:11124226 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
decreases activity affects binding |
ISO EXP |
Atovaquone results in decreased activity of DHODH protein Atovaquone binds to Dhodh protein |
CTD RGD |
PMID:10658902 PMID:15044733 |
RGD:2316233 |
NCBI chr19:37,551,858...37,573,327
Ensembl chr19:37,558,177...37,591,654
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions |
ISO |
Atovaquone inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate] |
CTD |
PMID:23769903 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
juglone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] |
CTD |
PMID:19269596 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Bad |
BCL2-associated agonist of cell death |
multiple interactions increases expression |
ISO |
[Indomethacin co-treated with juglone] results in increased expression of BAD mRNA; [Indomethacin co-treated with juglone] results in increased expression of BAD protein; [juglone co-treated with Ascorbic Acid] results in increased expression of BAD protein juglone results in increased expression of BAD mRNA; juglone results in increased expression of BAD protein |
CTD |
PMID:29992683 PMID:31916655 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
ISO |
[Indomethacin co-treated with juglone] results in increased expression of BAX mRNA; [Indomethacin co-treated with juglone] results in increased expression of BAX protein; [juglone co-treated with Ascorbic Acid] results in increased expression of BAX protein juglone results in increased expression of BAX mRNA; juglone results in increased expression of BAX protein |
CTD |
PMID:29992683 PMID:31916655 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
increases expression multiple interactions |
ISO |
juglone results in increased expression of BBC3 protein [Indomethacin co-treated with juglone] results in increased expression of BBC3 protein |
CTD |
PMID:31916655 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO |
[Indomethacin co-treated with juglone] results in decreased expression of BCL2 mRNA juglone results in decreased expression of BCL2 mRNA |
CTD |
PMID:31916655 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bid |
BH3 interacting domain death agonist |
multiple interactions |
ISO |
[juglone co-treated with Ascorbic Acid] affects the expression of BID protein |
CTD |
PMID:29992683 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression |
ISO |
[Indomethacin co-treated with juglone] results in increased expression of CASP3 mRNA; [juglone co-treated with Ascorbic Acid] results in decreased expression of CASP3 protein juglone results in increased expression of CASP3 mRNA |
CTD |
PMID:29992683 PMID:31916655 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases activity |
ISO |
juglone results in increased activity of CASP8 protein |
CTD |
PMID:20138029 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
[juglone co-treated with Ascorbic Acid] results in decreased activity of CAT protein |
CTD |
PMID:29992683 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression multiple interactions |
ISO |
juglone results in decreased expression of CCND1 mRNA; juglone results in decreased expression of CCND1 protein [Indomethacin co-treated with juglone] results in decreased expression of CCND1 mRNA; [Indomethacin co-treated with juglone] results in decreased expression of CCND1 protein |
CTD |
PMID:31916655 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd3 |
cyclin D3 |
decreases expression multiple interactions |
ISO |
juglone results in decreased expression of CCND3 protein Ascorbic Acid promotes the reaction [juglone results in decreased expression of CCND3 protein] |
CTD |
PMID:29992683 |
|
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
multiple interactions |
ISO |
[juglone co-treated with Ascorbic Acid] results in decreased expression of CDK4 protein |
CTD |
PMID:29992683 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions decreases expression |
ISO |
[Indomethacin co-treated with juglone] results in decreased expression of CTNNB1 mRNA; [Indomethacin co-treated with juglone] results in decreased expression of CTNNB1 protein juglone results in decreased expression of CTNNB1 mRNA; juglone results in decreased expression of CTNNB1 protein |
CTD |
PMID:31916655 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
ISO |
juglone results in increased expression of CYP1A1 mRNA |
CTD |
PMID:26558468 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Dab2 |
DAB adaptor protein 2 |
affects phosphorylation |
ISO |
juglone affects the phosphorylation of DAB2 protein |
CTD |
PMID:12881709 |
|
NCBI chr 2:55,514,692...55,567,476
Ensembl chr 2:55,514,700...55,567,476
|
|
G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
decreases activity |
ISO EXP |
juglone results in decreased activity of DHODH protein |
CTD |
PMID:10658902 |
|
NCBI chr19:37,551,858...37,573,327
Ensembl chr19:37,558,177...37,591,654
|
|
G |
E2f4 |
E2F transcription factor 4 |
multiple interactions |
ISO |
juglone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of E2F4 protein] |
CTD |
PMID:20479004 |
|
NCBI chr19:33,174,396...33,181,806
Ensembl chr19:33,174,410...33,181,806
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions |
ISO |
juglone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EGR1 protein] |
CTD |
PMID:20479004 |
|
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
ISO |
[juglone co-treated with Ascorbic Acid] results in decreased activity of GSR protein |
CTD |
PMID:29992683 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
multiple interactions decreases expression |
ISO |
[Indomethacin co-treated with juglone] results in decreased expression of HES1 mRNA; [Indomethacin co-treated with juglone] results in decreased expression of HES1 protein juglone results in decreased expression of HES1 mRNA; juglone results in decreased expression of HES1 protein |
CTD |
PMID:31916655 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions |
ISO |
juglone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein] |
CTD |
PMID:20479004 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
[juglone co-treated with Ascorbic Acid] results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:29992683 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
[juglone co-treated with Ascorbic Acid] results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:29992683 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
ISO |
[juglone co-treated with Ascorbic Acid] affects the expression of MMP2 mRNA |
CTD |
PMID:29992683 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO |
[juglone co-treated with Ascorbic Acid] results in decreased expression of MMP9 mRNA |
CTD |
PMID:29992683 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
ISO |
[juglone co-treated with Ascorbic Acid] results in increased degradation of PARP1 protein |
CTD |
PMID:29992683 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression multiple interactions |
ISO |
juglone results in decreased expression of PCNA protein [Indomethacin co-treated with juglone] results in decreased expression of PCNA protein |
CTD |
PMID:31916655 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pin1 |
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 |
multiple interactions |
ISO |
juglone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PIN1 mRNA]; juglone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of PIN1 protein]; juglone inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of PIN1 protein] |
CTD |
PMID:23754278 |
|
NCBI chr 8:19,189,408...19,200,785
Ensembl chr 8:19,189,373...19,200,785
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions increases expression |
ISO |
[Indomethacin co-treated with juglone] results in increased expression of PPARG mRNA; [Indomethacin co-treated with juglone] results in increased expression of PPARG protein juglone results in increased expression of PPARG mRNA; juglone results in increased expression of PPARG protein |
CTD |
PMID:31916655 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions decreases expression |
ISO |
[Indomethacin co-treated with juglone] results in decreased expression of PTGS2 mRNA; [Indomethacin co-treated with juglone] results in decreased expression of PTGS2 protein; [juglone co-treated with Ascorbic Acid] results in decreased expression of PTGS2 mRNA juglone results in decreased expression of PTGS2 mRNA; juglone results in decreased expression of PTGS2 protein |
CTD |
PMID:29992683 PMID:31916655 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Th |
tyrosine hydroxylase |
multiple interactions |
ISO |
juglone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of TH protein] |
CTD |
PMID:23754278 |
|
NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
multiple interactions |
ISO |
[juglone co-treated with Ascorbic Acid] affects the expression of TIMP1 mRNA |
CTD |
PMID:29992683 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
increases expression |
ISO |
juglone results in increased expression of TIMP2 mRNA |
CTD |
PMID:29992683 |
|
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions decreases expression |
ISO |
[Indomethacin co-treated with juglone] results in decreased expression of TNF mRNA; [Indomethacin co-treated with juglone] results in decreased expression of TNF protein juglone results in decreased expression of TNF mRNA; juglone results in decreased expression of TNF protein |
CTD |
PMID:31916655 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO |
[juglone co-treated with Ascorbic Acid] results in increased phosphorylation of TP53 protein |
CTD |
PMID:29992683 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
increases reduction |
ISO |
TXNRD1 protein results in increased reduction of juglone |
CTD |
PMID:21172426 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
increases reduction |
ISO |
TXNRD2 protein results in increased reduction of juglone |
CTD |
PMID:21172426 |
|
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO |
[juglone co-treated with Ascorbic Acid] results in decreased expression of VEGFA mRNA |
CTD |
PMID:29992683 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
decreases activity |
ISO EXP |
lapachol results in decreased activity of DHODH protein |
CTD |
PMID:10658902 |
|
NCBI chr19:37,551,858...37,573,327
Ensembl chr19:37,558,177...37,591,654
|
|
G |
Tp53 |
tumor protein p53 |
affects activity |
ISO |
lapachol affects the activity of TP53 protein |
CTD |
PMID:35435491 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
lawsone inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] |
CTD |
PMID:19269596 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
decreases activity |
ISO EXP |
lawsone results in decreased activity of DHODH protein |
CTD |
PMID:10658902 |
|
NCBI chr19:37,551,858...37,573,327
Ensembl chr19:37,558,177...37,591,654
|
|
G |
Mitf |
melanocyte inducing transcription factor |
decreases expression |
ISO |
lawsone results in decreased expression of MITF protein |
CTD |
PMID:25584612 |
|
NCBI chr 4:130,409,020...130,621,145
Ensembl chr 4:130,409,217...130,621,145
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
decreases expression |
ISO |
lawsone results in decreased expression of NFE2L2 mRNA |
CTD |
PMID:31967339 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases activity |
EXP |
lawsone results in increased activity of NQO1 protein |
CTD |
PMID:17265417 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Tyr |
tyrosinase |
multiple interactions |
ISO |
lawsone results in decreased expression of and results in decreased activity of TYR protein |
CTD |
PMID:25584612 |
|
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
|
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
ISO |
naphthazarin results in increased expression of CYP1A1 mRNA |
CTD |
PMID:26558468 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
decreases activity |
EXP ISO |
naphthazarin results in decreased activity of DHODH protein |
CTD |
PMID:10658902 |
|
NCBI chr19:37,551,858...37,573,327
Ensembl chr19:37,558,177...37,591,654
|
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases phosphorylation decreases expression decreases phosphorylation multiple interactions |
ISO EXP |
plumbagin results in increased phosphorylation of AKT1 protein plumbagin results in decreased expression of AKT1 mRNA plumbagin results in decreased phosphorylation of AKT1 protein plumbagin inhibits the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:20028456 PMID:32691977 PMID:36336213 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Bad |
BCL2-associated agonist of cell death |
multiple interactions |
EXP |
plumbagin inhibits the reaction [Doxorubicin results in increased expression of BAD protein] |
CTD |
PMID:32691977 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
EXP |
plumbagin results in decreased expression of BCL2 protein |
CTD |
PMID:34302802 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression |
ISO |
[Plumbagin alone or cotreated with IL-6] decreases expression of BCL2L1 mRNA in liver |
RGD |
PMID:25815436 |
RGD:126925996 |
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Casp3 |
caspase 3 |
increases activity multiple interactions |
ISO EXP |
plumbagin results in increased activity of CASP3 protein NFE2L2 protein mutant form affects the reaction [plumbagin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]]; plumbagin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]; plumbagin inhibits the reaction [Doxorubicin results in increased expression of CASP3 protein] |
CTD |
PMID:20028456 PMID:20576514 PMID:32691977 PMID:34302802 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases activity multiple interactions |
ISO |
plumbagin results in increased activity of CASP8 protein Acetylcysteine inhibits the reaction [plumbagin results in increased activity of CASP8 protein] |
CTD |
PMID:20576514 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases expression decreases expression increases activity |
ISO EXP |
Acetylcysteine inhibits the reaction [plumbagin results in increased activity of CASP9 protein] plumbagin results in increased expression of CASP9 mRNA plumbagin results in decreased expression of CASP9 protein |
CTD |
PMID:20576514 PMID:34302802 PMID:36336213 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
plumbagin inhibits the reaction [Doxorubicin results in decreased expression of CAT protein] |
CTD |
PMID:32691977 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
EXP |
plumbagin inhibits the reaction [Doxorubicin results in increased expression of CCL2 protein] |
CTD |
PMID:32691977 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
[Plumbagin alone or cotreated with IL-6] decreases expression of CCND1 mRNA in liver |
RGD |
PMID:25815436 |
RGD:126925996 |
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
plumbagin results in increased expression of CDKN1A mRNA |
CTD |
PMID:36336213 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Ctrl |
chymotrypsin-like |
multiple interactions decreases activity |
ISO |
Acetylcysteine inhibits the reaction [plumbagin results in decreased activity of CTRL protein] |
CTD |
PMID:31276663 |
|
NCBI chr19:33,827,279...33,829,129
Ensembl chr19:33,827,229...33,833,626
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
decreases expression |
EXP |
plumbagin results in decreased expression of CYP19A1 mRNA |
CTD |
PMID:34302802 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
increases expression multiple interactions |
ISO |
plumbagin results in increased expression of DDIT3 protein Acetylcysteine inhibits the reaction [plumbagin results in increased expression of DDIT3 protein]; Cycloheximide inhibits the reaction [plumbagin results in increased expression of DDIT3 protein] |
CTD |
PMID:31276663 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
decreases activity |
ISO EXP |
plumbagin results in decreased activity of DHODH protein |
CTD |
PMID:10658902 |
|
NCBI chr19:37,551,858...37,573,327
Ensembl chr19:37,558,177...37,591,654
|
|
G |
E2f1 |
E2F transcription factor 1 |
decreases expression |
ISO |
plumbagin results in decreased expression of E2F1 mRNA |
CTD |
PMID:36336213 |
|
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
|
|
G |
Fabp3 |
fatty acid binding protein 3 |
multiple interactions |
EXP |
plumbagin inhibits the reaction [Doxorubicin results in increased expression of FABP3 protein] |
CTD |
PMID:32691977 |
|
NCBI chr 5:142,651,962...142,658,707
Ensembl chr 5:142,651,956...142,658,718
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
plumbagin results in increased expression of FAS mRNA; plumbagin results in increased expression of FAS protein |
CTD |
PMID:20576514 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Fshr |
follicle stimulating hormone receptor |
decreases expression |
EXP |
plumbagin results in decreased expression of FSHR mRNA |
CTD |
PMID:34302802 |
|
NCBI chr 6:5,198,825...5,406,785
Ensembl chr 6:5,198,825...5,406,785
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
multiple interactions |
EXP |
plumbagin inhibits the reaction [Streptozocin results in increased activity of G6PC1 protein] |
CTD |
PMID:22960630 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
increases expression |
ISO |
plumbagin results in increased expression of GCLM mRNA |
CTD |
PMID:20028456 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression |
ISO |
plumbagin results in increased expression of GSTP1 mRNA |
CTD |
PMID:20028456 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Hk1 |
hexokinase 1 |
multiple interactions |
EXP |
plumbagin inhibits the reaction [Streptozocin results in decreased activity of HK1 protein] |
CTD |
PMID:22960630 |
|
NCBI chr20:30,230,488...30,332,099
Ensembl chr20:30,230,486...30,332,131
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [plumbagin results in increased expression of HMOX1 protein]; NFE2L2 mRNA affects the reaction [plumbagin results in increased expression of HMOX1 mRNA]; wortmannin inhibits the reaction [plumbagin results in increased expression of HMOX1 protein] plumbagin promotes the reaction [Doxorubicin results in increased expression of HMOX1 mRNA] plumbagin results in increased expression of HMOX1 mRNA; plumbagin results in increased expression of HMOX1 protein |
CTD |
PMID:20028456 PMID:32691977 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression multiple interactions |
ISO |
plumbagin results in increased expression of HSPA5 protein Acetylcysteine inhibits the reaction [plumbagin results in increased expression of HSPA5 protein]; Cycloheximide inhibits the reaction [plumbagin results in increased expression of HSPA5 protein] |
CTD |
PMID:31276663 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO EXP |
plumbagin inhibits the reaction [IFNG protein results in increased abundance of Nitrites] plumbagin inhibits the reaction [Doxorubicin results in increased expression of IFNG protein] |
CTD |
PMID:23942037 PMID:32691977 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
EXP |
plumbagin inhibits the reaction [Streptozocin results in decreased expression of INS1 protein] |
CTD |
PMID:22960630 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation |
ISO |
plumbagin results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:20028456 PMID:20576514 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation |
ISO |
plumbagin results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:20028456 PMID:20576514 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions decreases expression |
ISO |
plumbagin results in decreased expression of and results in decreased activity of MMP2 protein plumbagin results in decreased expression of MMP2 mRNA |
CTD |
PMID:36336213 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression |
ISO |
[Plumbagin alone and cotreated with IL-6] decreases expression of MMP9 in liver plumbagin results in decreased expression of MMP9 mRNA |
CTD RGD |
PMID:36336213 PMID:25815436 |
RGD:126925996 |
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions affects localization affects response to substance |
ISO EXP |
NFE2L2 mRNA affects the reaction [plumbagin results in decreased susceptibility to tert-Butylhydroperoxide]; NFE2L2 mRNA affects the reaction [plumbagin results in increased expression of HMOX1 mRNA] plumbagin affects the localization of NFE2L2 protein NFE2L2 protein mutant form affects the reaction [plumbagin inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased activity of CASP3 protein]] NFE2L2 mRNA affects the susceptibility to plumbagin |
CTD |
PMID:20028456 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nppb |
natriuretic peptide B |
multiple interactions |
EXP |
plumbagin inhibits the reaction [Doxorubicin results in increased expression of NPPB protein] |
CTD |
PMID:32691977 |
|
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression multiple interactions |
ISO |
plumbagin results in increased expression of NQO1 mRNA; plumbagin results in increased expression of NQO1 protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [plumbagin results in increased expression of NQO1 protein]; wortmannin inhibits the reaction [plumbagin results in increased expression of NQO1 protein] |
CTD |
PMID:20028456 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
decreases expression |
ISO |
plumbagin results in decreased expression of PARP1 mRNA; plumbagin results in decreased expression of PARP1 protein |
CTD |
PMID:36336213 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Per2 |
period circadian regulator 2 |
decreases response to substance |
ISO |
PER2 protein mutant form results in decreased susceptibility to plumbagin |
CTD |
PMID:25628599 |
|
NCBI chr 9:92,007,289...92,049,551
Ensembl chr 9:92,007,296...92,049,459
|
|
G |
Pgr |
progesterone receptor |
decreases expression |
EXP |
plumbagin results in decreased expression of PGR mRNA |
CTD |
PMID:34302802 |
|
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Pten |
phosphatase and tensin homolog |
multiple interactions |
EXP |
plumbagin inhibits the reaction [Doxorubicin results in decreased phosphorylation of PTEN protein] |
CTD |
PMID:32691977 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptpn2 |
protein tyrosine phosphatase, non-receptor type 2 |
multiple interactions |
ISO |
plumbagin binds to and results in decreased activity of PTPN2 protein |
CTD |
PMID:31248982 |
|
NCBI chr18:61,229,012...61,294,662
Ensembl chr18:61,229,014...61,294,627
|
|
G |
Pygb |
glycogen phosphorylase B |
multiple interactions |
EXP |
plumbagin inhibits the reaction [Doxorubicin results in increased expression of PYGB protein] |
CTD |
PMID:32691977 |
|
NCBI chr 3:139,611,724...139,658,521
Ensembl chr 3:139,611,749...139,663,553
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
multiple interactions |
EXP |
plumbagin inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 mRNA]; plumbagin inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 protein] |
CTD |
PMID:22960630 |
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression |
ISO |
plumbagin results in increased expression of SQSTM1 protein |
CTD |
PMID:31276663 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Tesk1 |
testis associated actin remodelling kinase 1 |
decreases expression |
EXP |
plumbagin results in decreased expression of TESK1 mRNA |
CTD |
PMID:34302802 |
|
NCBI chr 5:57,691,922...57,697,698
Ensembl chr 5:57,691,969...57,697,698
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP |
plumbagin inhibits the reaction [Doxorubicin results in increased expression of TGFB1 protein] |
CTD |
PMID:32691977 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
increases expression |
ISO |
plumbagin results in increased expression of TIMP2 mRNA |
CTD |
PMID:36336213 |
|
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Tnni3 |
troponin I3, cardiac type |
multiple interactions |
EXP |
plumbagin inhibits the reaction [Doxorubicin results in increased expression of TNNI3 protein] |
CTD |
PMID:32691977 |
|
NCBI chr 1:69,299,900...69,303,582
Ensembl chr 1:69,299,900...69,303,580
|
|
G |
Tp53 |
tumor protein p53 |
increases expression |
EXP |
plumbagin results in increased expression of TP53 protein |
CTD |
PMID:34302802 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
increases expression |
ISO |
plumbagin results in increased expression of TXNRD1 mRNA |
CTD |
PMID:20028456 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases glucuronidation |
ISO |
UGT1A1 protein results in increased glucuronidation of plumbagin |
CTD |
PMID:14557274 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation |
ISO |
UGT1A9 protein results in increased glucuronidation of plumbagin |
CTD |
PMID:14557274 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Uhrf1 |
ubiquitin-like with PHD and ring finger domains 1 |
decreases expression |
ISO |
plumbagin results in decreased expression of UHRF1 mRNA; plumbagin results in decreased expression of UHRF1 protein |
CTD |
PMID:36336213 |
|
NCBI chr 9:1,133,117...1,154,639
Ensembl chr 9:1,134,909...1,154,631
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression |
ISO |
Plumbagin decreases expression of VEGFA mRNA in liver |
RGD |
PMID:25815436 |
RGD:126925996 |
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
decreases expression |
ISO |
shikonin results in decreased expression of ACTA2 mRNA |
CTD |
PMID:25591861 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation multiple interactions |
ISO |
shikonin results in decreased phosphorylation of AKT1 protein shikonin promotes the reaction [Oxygen deficiency results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:24463199 PMID:28684144 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Areg |
amphiregulin |
decreases expression |
ISO |
shikonin results in decreased expression of AREG mRNA |
CTD |
PMID:37268198 |
|
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Atf3 |
activating transcription factor 3 |
multiple interactions increases expression |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of ATF3 mRNA] shikonin results in increased expression of ATF3 protein shikonin results in increased expression of ATF3 mRNA; shikonin results in increased expression of ATF3 protein [shikonin results in increased acetylation of HDAC1 protein] which results in increased expression of ATF3 protein; ATF3 protein promotes the reaction [shikonin results in decreased expression of GPX4 protein]; ATF3 protein promotes the reaction [shikonin results in decreased expression of SLC7A11 protein]; MYC protein inhibits the reaction [shikonin results in increased expression of ATF3 mRNA]; MYC protein inhibits the reaction [shikonin results in increased expression of ATF3 protein]; shikonin promotes the reaction [HDAC1 protein binds to ATF3 promoter] |
CTD |
PMID:25451590 PMID:37268198 |
|
NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631
|
|
G |
Atf6 |
activating transcription factor 6 |
multiple interactions |
EXP |
shikonin inhibits the reaction [Glutamic Acid results in increased expression of ATF6 protein] |
CTD |
PMID:35028790 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP |
[Enzyme Activators results in increased activity of EIF2AK3 protein] inhibits the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased expression of BAX protein]]; shikonin inhibits the reaction [Glutamic Acid results in increased expression of and affects the localization of BAX protein]; shikonin inhibits the reaction [Thapsigargin results in increased expression of BAX protein] |
CTD |
PMID:35028790 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO EXP |
shikonin results in decreased expression of BCL2 protein 1,3-benzothiazol-2-yl(2-((2-(3-pyridinyl)ethyl)amino)-4-pyrimidinyl)acetonitrile promotes the reaction [shikonin inhibits the reaction [Glutamic Acid results in decreased expression of BCL2 protein]]; MKC8866 promotes the reaction [shikonin inhibits the reaction [Glutamic Acid results in decreased expression of BCL2 protein]]; shikonin inhibits the reaction [Glutamic Acid results in decreased expression of BCL2 protein]; shikonin inhibits the reaction [Thapsigargin results in decreased expression of BCL2 protein]; ursodoxicoltaurine inhibits the reaction [shikonin inhibits the reaction [Glutamic Acid results in decreased expression of BCL2 protein]] |
CTD |
PMID:25591861 PMID:35028790 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Casp12 |
caspase 12 |
multiple interactions |
EXP |
[Enzyme Activators results in increased activity of EIF2AK3 protein] inhibits the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased cleavage of CASP12 protein]]; shikonin inhibits the reaction [Glutamic Acid results in increased expression of and results in increased cleavage of CASP12 protein] |
CTD |
PMID:35028790 |
|
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
|
|
G |
Casp3 |
caspase 3 |
increases cleavage multiple interactions |
ISO EXP |
shikonin results in increased cleavage of CASP3 protein shikonin inhibits the reaction [Benzene results in increased expression of CASP3 mRNA] shikonin inhibits the reaction [Glutamic Acid results in increased expression of CASP3 protein modified form] |
CTD |
PMID:25591861 PMID:35028790 PMID:36306860 PMID:37268198 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Benzene results in increased expression of CASP7 mRNA] |
CTD |
PMID:36306860 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Benzene results in increased cleavage of CASP9 protein]; shikonin inhibits the reaction [Benzene results in increased expression of CASP9 mRNA] |
CTD |
PMID:36306860 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccl1 |
C-C motif chemokine ligand 1 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of CCL1 mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr10:67,128,331...67,131,109
Ensembl chr10:67,128,331...67,131,159
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of CCL4 mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of CCL4 mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of CCL7 mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of CCL7 mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
EXP ISO |
shikonin results in decreased expression of CCND1 protein |
CTD |
PMID:16061028 PMID:28684144 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression |
EXP |
shikonin results in decreased expression of CCNE1 protein |
CTD |
PMID:16061028 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions increases expression |
ISO |
shikonin inhibits the reaction [[Tobacco Smoke Pollution results in increased abundance of Particulate Matter] which results in decreased expression of CDH1 protein] shikonin results in increased expression of CDH1 protein |
CTD |
PMID:35787437 PMID:37268198 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh2 |
cadherin 2 |
multiple interactions decreases expression |
ISO |
shikonin inhibits the reaction [[Tobacco Smoke Pollution results in increased abundance of Particulate Matter] which results in increased expression of CDH2 protein] shikonin results in decreased expression of CDH2 protein |
CTD |
PMID:35787437 PMID:37268198 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO EXP |
shikonin results in increased expression of CDKN1A protein |
CTD |
PMID:16061028 PMID:28684144 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
decreases expression |
ISO |
shikonin results in decreased expression of COL1A1 mRNA |
CTD |
PMID:25591861 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
decreases expression |
ISO |
shikonin results in decreased expression of COL3A1 mRNA |
CTD |
PMID:25591861 |
|
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
|
|
G |
Csf1 |
colony stimulating factor 1 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of CSF1 mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704
|
|
G |
Csrnp1 |
cysteine and serine rich nuclear protein 1 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of AXUD1 mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of AXUD1 mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions |
ISO |
shikonin inhibits the reaction [[Tobacco Smoke Pollution results in increased abundance of Particulate Matter] which results in increased expression of CXCL1 protein] |
CTD |
PMID:35787437 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity |
EXP ISO |
shikonin results in decreased activity of CYP1A2 protein |
CTD |
PMID:28941798 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
decreases activity |
EXP |
shikonin results in decreased activity of CYP2B1 protein |
CTD |
PMID:28941798 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
decreases activity |
ISO |
shikonin results in decreased activity of CYP2B6 protein |
CTD |
PMID:28941798 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
decreases activity |
EXP ISO |
shikonin results in decreased activity of CYP2C11 protein shikonin results in decreased activity of CYP2C9 protein |
CTD |
PMID:28941798 |
|
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2d1 |
cytochrome P450, family 2, subfamily d, polypeptide 1 |
decreases activity |
EXP |
shikonin results in decreased activity of CYP2D1 protein |
CTD |
PMID:28941798 |
|
NCBI chr 7:113,908,950...113,913,420
Ensembl chr 7:113,908,947...113,922,084
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
decreases activity |
ISO |
shikonin results in decreased activity of CYP2D6 protein |
CTD |
PMID:28941798 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases activity |
ISO EXP |
shikonin results in decreased activity of CYP2E1 protein |
CTD |
PMID:28941798 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions decreases activity |
EXP ISO |
shikonin inhibits the reaction [CYP3A2 protein results in increased hydroxylation of Midazolam] shikonin results in decreased activity of CYP3A2 protein shikonin results in decreased activity of CYP3A4 protein |
CTD |
PMID:28941798 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
EXP |
[Enzyme Activators results in increased activity of EIF2AK3 protein] inhibits the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased expression of DDIT3 protein]]; shikonin inhibits the reaction [Glutamic Acid results in increased expression of DDIT3 protein] |
CTD |
PMID:35028790 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of DUSP1 mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of DUSP1 mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Calcimycin results in increased expression of DUSP6 mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Egr2 |
early growth response 2 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of EGR2 mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of EGR2 mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
|
|
G |
Egr3 |
early growth response 3 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of EGR3 mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of EGR3 mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions |
EXP |
[Enzyme Activators results in increased activity of EIF2AK3 protein] inhibits the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased cleavage of CASP12 protein]]; [Enzyme Activators results in increased activity of EIF2AK3 protein] inhibits the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased expression of BAX protein]]; [Enzyme Activators results in increased activity of EIF2AK3 protein] inhibits the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased expression of DDIT3 protein]]; GSK2656157 promotes the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased phosphorylation of EIF2AK3 protein]]; shikonin inhibits the reaction [Glutamic Acid results in increased phosphorylation of EIF2AK3 protein]; shikonin inhibits the reaction [Thapsigargin results in increased phosphorylation of EIF2AK3 protein]; ursodoxicoltaurine promotes the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased phosphorylation of EIF2AK3 protein]] |
CTD |
PMID:35028790 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
multiple interactions |
EXP |
GSK2656157 promotes the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased phosphorylation of EIF2S1 protein]]; shikonin inhibits the reaction [Glutamic Acid results in increased phosphorylation of EIF2S1 protein]; shikonin inhibits the reaction [Thapsigargin results in increased phosphorylation of EIF2S1 protein]; ursodoxicoltaurine promotes the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased phosphorylation of EIF2S1 protein]] |
CTD |
PMID:35028790 |
|
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
multiple interactions |
ISO |
shikonin affects the reaction [Oxygen deficiency affects the phosphorylation of EIF4EBP1 protein] |
CTD |
PMID:28684144 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions |
EXP |
shikonin inhibits the reaction [Glutamic Acid results in increased phosphorylation of ERN1 protein] |
CTD |
PMID:35028790 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of FOS mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of FOS mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of FOSB mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of FOSB mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
decreases expression multiple interactions |
ISO |
shikonin results in decreased expression of GPX4 protein ATF3 protein promotes the reaction [shikonin results in decreased expression of GPX4 protein] |
CTD |
PMID:37268198 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Hdac1 |
histone deacetylase 1 |
multiple interactions |
ISO |
[shikonin results in increased acetylation of HDAC1 protein] which results in increased expression of ATF3 protein; shikonin promotes the reaction [HDAC1 protein binds to ATF3 promoter] |
CTD |
PMID:37268198 |
|
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
decreases expression multiple interactions |
ISO |
shikonin results in decreased expression of HIF1A protein shikonin inhibits the reaction [Oxygen deficiency results in increased expression of HIF1A protein] |
CTD |
PMID:28684144 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hsf1 |
heat shock transcription factor 1 |
increases activity |
ISO |
shikonin results in increased activity of HSF1 protein |
CTD |
PMID:34170685 |
|
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
|
|
G |
Il13 |
interleukin 13 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of IL13 mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of IL13 mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
shikonin inhibits the reaction [Benzene results in increased expression of IL1B mRNA] |
CTD |
PMID:36306860 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Itgb1 |
integrin subunit beta 1 |
decreases expression |
ISO |
shikonin results in decreased expression of ITGB1 mRNA; shikonin results in decreased expression of ITGB1 protein |
CTD |
PMID:23562787 |
|
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
shikonin inhibits the reaction [Calcimycin results in increased expression of JUN mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of MAP3K8 mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of MAP3K8 mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions decreases phosphorylation increases phosphorylation |
ISO |
Acetylcysteine inhibits the reaction [shikonin results in decreased phosphorylation of MAPK1 protein] shikonin results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:23562787 PMID:24463199 PMID:25591861 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases phosphorylation multiple interactions increases phosphorylation |
ISO |
shikonin results in decreased phosphorylation of MAPK3 protein Acetylcysteine inhibits the reaction [shikonin results in decreased phosphorylation of MAPK3 protein] shikonin results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:23562787 PMID:24463199 PMID:25591861 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
EXP |
shikonin inhibits the reaction [Glutamic Acid results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:35028790 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions |
EXP |
shikonin inhibits the reaction [Glutamic Acid results in increased phosphorylation of MAPK9 protein] |
CTD |
PMID:35028790 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases expression |
ISO |
shikonin results in decreased expression of MMP2 protein |
CTD |
PMID:37268198 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
decreases expression |
ISO |
shikonin results in decreased expression of MMP3 protein |
CTD |
PMID:37268198 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mmp7 |
matrix metallopeptidase 7 |
decreases expression |
ISO |
shikonin results in decreased expression of MMP7 protein |
CTD |
PMID:37268198 |
|
NCBI chr 8:4,848,186...4,855,908
Ensembl chr 8:4,848,186...4,855,902
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression |
ISO |
shikonin results in decreased expression of MMP9 protein |
CTD |
PMID:37268198 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mt2A |
metallothionein 2A |
multiple interactions |
ISO |
shikonin inhibits the reaction [Calcimycin results in increased expression of MT2 mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions |
ISO |
shikonin inhibits the reaction [Oxygen deficiency results in increased phosphorylation of MTOR protein] |
CTD |
PMID:28684144 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions |
ISO |
MYC protein inhibits the reaction [shikonin results in increased expression of ATF3 mRNA]; MYC protein inhibits the reaction [shikonin results in increased expression of ATF3 protein] |
CTD |
PMID:37268198 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Benzene results in increased expression of and affects the localization of NFE2L2 protein] |
CTD |
PMID:36306860 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbid |
NFKB inhibitor delta |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of NFKBID mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of NFKBID mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr 1:85,679,353...85,690,415
Ensembl chr 1:85,680,861...85,690,447
|
|
G |
Nfkbiz |
NFKB inhibitor zeta |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of NFKBIZ mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of NFKBIZ mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
|
|
G |
Nkd2 |
NKD inhibitor of WNT signaling pathway 2 |
decreases expression |
ISO |
shikonin results in decreased expression of NKD2 mRNA |
CTD |
PMID:37268198 |
|
NCBI chr 1:29,442,898...29,470,839
Ensembl chr 1:29,441,328...29,470,821
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of NR4A1 mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of NR4A1 mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
|
|
G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of NR4A2 mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of NR4A2 mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
|
|
G |
Nr4a3 |
nuclear receptor subfamily 4, group A, member 3 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of NR4A3 mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of NR4A3 mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr 5:62,361,588...62,401,489
Ensembl chr 5:62,361,822...62,402,733
|
|
G |
Olr1 |
oxidized low density lipoprotein receptor 1 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of OLR1 mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr 4:162,926,436...162,949,057
Ensembl chr 4:162,926,439...162,948,523
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage multiple interactions |
ISO |
shikonin results in increased cleavage of PARP1 protein Acetylcysteine inhibits the reaction [shikonin results in increased cleavage of PARP1 protein] |
CTD |
PMID:24463199 PMID:37268198 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
EXP |
shikonin results in decreased expression of PCNA protein |
CTD |
PMID:16061028 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pkm |
pyruvate kinase M1/2 |
multiple interactions |
ISO |
shikonin inhibits the reaction [[Tobacco Smoke Pollution results in increased abundance of Particulate Matter] which results in increased expression of PKM protein] |
CTD |
PMID:35787437 |
|
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
|
|
G |
Plk3 |
polo-like kinase 3 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Calcimycin results in increased expression of PLK3 mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr 5:130,607,142...130,612,317
Ensembl chr 5:130,607,142...130,612,317
|
|
G |
Ppp1r15a |
protein phosphatase 1, regulatory subunit 15A |
multiple interactions |
ISO |
shikonin inhibits the reaction [Calcimycin results in increased expression of PPP1R15A mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of PTGS2 mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of PTGS2 mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
shikonin inhibits the reaction [Benzene results in increased expression of RELA protein] |
CTD |
PMID:36306860 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Ripk1 |
receptor interacting serine/threonine kinase 1 |
multiple interactions |
ISO |
shikonin promotes the reaction [RIPK1 protein binds to RIPK3 protein] |
CTD |
PMID:23261677 |
|
NCBI chr17:30,839,639...30,871,824
Ensembl chr17:30,839,650...30,871,824
|
|
G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
multiple interactions |
ISO |
shikonin promotes the reaction [RIPK1 protein binds to RIPK3 protein] |
CTD |
PMID:23261677 |
|
NCBI chr15:29,283,153...29,292,107
Ensembl chr15:29,283,145...29,292,121
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
multiple interactions |
ISO |
shikonin promotes the reaction [Oxygen deficiency results in decreased phosphorylation of RPS6KB1 protein] |
CTD |
PMID:28684144 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Serpine1 |
serpin family E member 1 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of SERPINE1 mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Slc7a11 |
solute carrier family 7 member 11 |
multiple interactions decreases expression |
ISO |
ATF3 protein promotes the reaction [shikonin results in decreased expression of SLC7A11 protein] |
CTD |
PMID:37268198 |
|
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
|
|
G |
Snai1 |
snail family transcriptional repressor 1 |
decreases expression |
ISO |
shikonin results in decreased expression of SNAI1 protein |
CTD |
PMID:37268198 |
|
NCBI chr 3:156,248,479...156,252,969
Ensembl chr 3:156,248,485...156,252,969
|
|
G |
Snai2 |
snail family transcriptional repressor 2 |
decreases expression |
ISO |
shikonin results in decreased expression of SNAI2 protein |
CTD |
PMID:37268198 |
|
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
|
|
G |
Tagap |
T-cell activation RhoGTPase activating protein |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of TAGAP mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of TAGAP mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr 1:47,170,725...47,179,705
Ensembl chr 1:47,170,725...47,179,792
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
increases expression |
ISO |
shikonin results in increased expression of TIMP2 protein |
CTD |
PMID:37268198 |
|
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
shikonin inhibits the reaction [[Tobacco Smoke Pollution results in increased abundance of Particulate Matter] which results in increased expression of TNF protein]; shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of TNF mRNA]; shikonin inhibits the reaction [Benzene results in increased expression of TNF mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of TNF mRNA] |
CTD |
PMID:25451590 PMID:35787437 PMID:36306860 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
increases expression |
ISO |
shikonin results in increased expression of TP53 protein |
CTD |
PMID:28684144 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
multiple interactions |
EXP ISO |
shikonin inhibits the reaction [UGT1A1 protein results in increased glucuronidation of Estradiol] |
CTD |
PMID:31128210 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
multiple interactions |
ISO |
shikonin inhibits the reaction [UGT1A3 protein results in increased glucuronidation of Chenodeoxycholic Acid] |
CTD |
PMID:31128210 |
|
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
multiple interactions |
ISO |
shikonin inhibits the reaction [UGT1A9 protein results in increased glucuronidation of Propofol] |
CTD |
PMID:31128210 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b7 |
UDP glucuronosyltransferase family 2 member B7 |
multiple interactions |
ISO |
shikonin inhibits the reaction [UGT2B7 protein results in increased glucuronidation of Zidovudine] |
CTD |
PMID:31128210 |
|
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
|
|
G |
Xbp1 |
X-box binding protein 1 |
multiple interactions |
EXP |
MKC8866 promotes the reaction [shikonin inhibits the reaction [Glutamic Acid results in increased expression of XBP1 protein alternative form]]; shikonin inhibits the reaction [Glutamic Acid results in increased expression of XBP1 protein alternative form] |
CTD |
PMID:35028790 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|
G |
Zfp36 |
zinc finger protein 36 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of ZFP36 mRNA]; shikonin inhibits the reaction [Calcimycin results in increased expression of ZFP36 mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr 1:83,669,084...83,671,564
Ensembl chr 1:83,669,084...83,671,564
|
|
G |
Zfp36l1 |
zinc finger protein 36, C3H type-like 1 |
multiple interactions |
ISO |
shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of ZFP36L1 mRNA] |
CTD |
PMID:25451590 |
|
NCBI chr 6:98,930,705...98,935,748
Ensembl chr 6:98,930,718...98,935,748
|
|